A new member of the IL-1 receptor family highly expressed in hippocampus and involved in X-linked mental retardation

Nature Genetics

Volumn 23, Issue 1, 1999, Pages 25-31

  Carrié, Alain ^a   Jun, Lin ^b   Bienvenu, Thierry ^a   Vinet, Marie Claude ^a   McDonell, Nathalie ^a   Couvert, Philippe ^a   Zemni, Ramzi ^a   Cardona, Ana ^c   Van Buggenhout, Griet ^d,e   Frints, Suzanna ^b,d   Hamel, Ben ^e   Moraine, Claude ^f   Ropers, Hans H ^g   Strom, Tim ^h   Howell, Gareth R ⁱ   Whittaker, Adam ⁱ   Ross, Mark T ⁱ   Kahn, Axel ^a   Fryns, Jean Pierre ^d   Beldjord, Cherif ^a   Marynen, Peter ^b   Chelly, Jamel ^a   more..

^a INSERM Unité 129 ICGM CHU Cochin ^*  (France)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^c INSTITUT PASTEUR   (France)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^f CHU BRETONNEAU   (France)

^g MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

^h Abteilung Medizinische Genetik   (Germany)

ⁱ WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; INTERLEUKIN 1 RECEPTOR;

ADULT; ARTICLE; CHROMOSOME MAP; CHROMOSOME XP; CLINICAL FEATURE; COGNITION; CONTROLLED STUDY; EMBRYO; FETUS; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LEARNING; MEMORY; MENTAL DEFICIENCY; MOUSE; NONHUMAN; NONSENSE MUTATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; X CHROMOSOME LINKED DISORDER;

EID: 0032819848     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/12623     Document Type: Article

References (40)

1. Moser, H.W., Ramey, C.T. & Leonard, C.O. Principles and Practice of Medical Genetics (eds Emery, A.E.H. & Rimoin, D.L.) (Churchill Livingstone, Edinburgh, 1983).
2. Hagberg, B. & Kyllerman, M. Epidemiology of mental retardation. A Swedish survey. Brain Dev. 5, 441-449 (1983).
3. Lubs, H.A. et al. XLMR genes: update 1998. Am. J. Med. Genet. 64, 147-157 (1998).
4. Gedeon, A.K., Donnelly, A.J., Mulley, J.C., Kerr, B. & Turner, G. How many X-linked genes for non-specific mental retardation (MRX) are there? Am. J. Med. Genet. 64, 158-162 (1996).
5. des Portes, V. et al. X-linked nonspecific mental retardation (MRX) linkage studies in 25 unrelated families: the European XLMR consortium. Am. J. Med. Genet. 85, 263-265 (1999).
6. Gecz, J., Gedeon, A., Sutherland, G. & Mulley, J. Identification of the gene FMR2, associated with FRAX-E mental retardation. Nature Genet. 13, 105-108 (1996).
7. Billuart, P. et al. Oligophrenin 1, a novel gene encoding a rho-GAP protein involved in X-linked non-specific mental retardation. Nature 392, 923-926 (1998).
8. Allen, K.M. et al. PAK3 mutation in nonsyndromic X-linked mental retardation. Nature Genet. 20, 25-30 (1998).
9. Hall, A. RhoGTPases and the actin cytoskeleton. Science 279, 509-514 (1998).
10. D'Adamo, P. et al. Mutations in GDI1 are responsible for X-linked mental retardation. Nature Genet. 19, 134-139 (1998).
11. Bienvenu, T. et al. Non-specific X-linked semidominant mental retardation by mutations in a Rab GDP-dissociation inhibitor. Hum. Mol. Genet. 7, 1311-1315 (1998).
12. Südhof, T.C. Function of Rab3 GDP-GTP exchange. Neuron 18, 519-522 (1997).
13. Novick, P. & Zerial, M. The diversity of Rab proteins in vesicle transport. Curr. Opin. Cell Biol. 9, 496-504 (1997).
14. Castillo, P.E. et al. Rab3 is essential for mossy fibre long-term potentiation in the hippocampus. Nature 388, 590-593 (1997).
15. Fries, M.H. et al. Mental retardation locus in Xp21 chromosome microdeletion. Am. J. Med. Genet. 46, 363-368 (1993).
16. Raeymaekers, P. et al. A form of non-specific mental retardation is probably caused by a microdeletion in a Belgian family. Am J. Med. Genet. 64, 16 (1996).
17. Billuart, P. et al. Identification by STS PCR screening of a microdeletion in Xp21.3-22.1 associated with non-specific mental retardation. Hum. Mol. Genet. 5, 977-979 (1996).
18. des Portes, V. et al. Inherited microdeletion in Xp21.3-22.1 involved in non-specific mental retardation. Clin. Genet. 53, 136-141 (1998).
19. Solovyev, V.V., Salsmov, A.A. & Lawrence, C.B. Predicting internal exons by oligonucleotide composition and discriminant analysis of spliceable open reading frame. Nucleic Acids Res. 22, 5156-5163 (1994).
20. Huang, I., Gao, X., Li, S. & Cao, Z. Recruitment of IRAK to the interleukin 1 receptor complex requires interleukin 1 receptor accessory protein. Proc. Natl Acad. Sci. USA 94, 12829-12832 (1997).
21. Greenfeder, S.A. et al. Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex. J. Biol. Chem. 270, 13757-13765 (1995).
22. Kozak, M. An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res. 15, 8125-8148 (1987).
23. Sims, J.E. et al. cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily. Science 241, 585-589 (1988).
24. Kopp, E.B. & Medzhitov, R. The toll-receptor family and control of innate immunity. Curr. Opin. Immunol. 11, 13-18 (1999).
25. Kocsis, B. & Vertes, R.P. Characterization of neurons of the supramammillary nucleus and mammillary body that discharge rhythmically with the hippocampal θ rhythm in the rat. J. Neurosci. 14, 7040-7052 (1994).
26. Milner, B., Squire, L.R. & Kandel, E.R. Cognitive neuroscience and the study of memory. Neuron 20, 445-468 (1998).
27. Tsien, J.Z., Huerta, P.T. & Tonegawa, S. The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory. Cell 87, 1327-1338 (1996).
28. Bliss, T.V.P. & Collingridge, L.G. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361, 31-39 (1993).
29. Ninomiya-Tsuji, J. et al. The kinase TAK1 can activate the NIK-IκB as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature 398, 252-256 (1999).
30. Dinarello, C.A. Biologic basis for interleukin-1 in disease. Blood 87, 2095-2147 (1996).
31. Cao, Z., Henzel, W.J. & Cao, X. IRAK: a kinase associated with the interleukin-1 receptor. Science 271, 1128-1131 (1996).
32. Crumeyrolle-Arias, M. et al. Radioimagers as an alternative to film autoradiography for in situ quantitative analysis of 125I-ligand receptor binding and pharmacological studies. Histochem. J. 28, 801-809 (1996).
33. Bianchi, M., Sacerdote, P. & Panerai, A.E. Cytokines and cognitive functions in mice. Biol. Signals Recept. 7, 45-54 (1998).
34. Katsuki, H. et al. Interleukin-1 inhibits long-term potentiation in the CA3 region of mouse hippocampal slices. Eur. J. Pharmacol. 181, 323-326 (1990).
35. Rada, P. et al. Interleukin-1β decreases acethylcholine measured by microdialysis in the hippocampus of freely moving rats. Brain Res. 550, 287-290 (1991).
36. Cassel, J.C. & Jeltsch, H. Serotonergic modulation of cholinergic function in the central nervous system: cognitive implications. Neuroscience 69, 1-41 (1995).
37. Da Silva, J., Pierrat, B., Mary, J.L. & Lesslauer, W. Blockade of p38 Mitogen-activated protein kinase pathway inhibits inducible nitric-oxide synthase expression in mouse astrocytes. J. Biol. Chem. 272, 28373-28380 (1997).
38. Ferrero, G.B. et al. An integrated physical map and genetic map of a 35 Mb region on chromosome Xp22.3-Xp21.3. Hum. Mol. Genet. 4, 1821-1827 (1995).
39. Lehrach, H. et al. Hybridization fingerprinting in genome mapping and sequencing. Genome Analysis Vol 1: Genetic and Physical Mapping (eds Davies, K.E. & Tilghman, S.M.) 39-81 (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 1990).
40. Muscatelli, F. et al. Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism. Nature 372, 672-676 (1994).